Guidance from the National Institute for Health and Clinical Excellence (NICE, 2012) states that current evidence on the efficacy of breast reconstruction using lipomodelling after breast cancer treatment is adequate and the evidence raises no major safety concerns. The guidance noted that there is a...
This cohort study evaluates the risk of endometrial polyps, hyperplasia, carcinoma, and uterine cancer after tamoxifen treatment among premenopausal
The prognosis is generally very good, but nevertheless many patients still die of breast cancer every year. The general aim of this thesis is to gain increased knowledge of brain metastases due to breast cancer, including incidence, predictors and treatment aspects and better knowledge of the ...
(in days) between biopsy and the beginning of treatment. The odds ratios were estimated from a generalized linear mixed model, adjusted by age, number of comorbid conditions, marital status, size of residence, cancer stage, estrogen receptor/progesterone receptor status, tumor size, nodal status,...
Gene expression tests can inform decisions on whether to recommend chemotherapy for patients with HR+, HER2- early breast cancer. The goal of this analysis was to compare treatment costs by an expanded budget impact model of reimbursed gene expression tests in Germany. Methods A cost comparison wa...
e18881#Background:After diagnosis and treatment, women with cancer often experience significant functional decline from which most do not recover. Functional deficits, especially when persistent, are related to poorer health and quality of life (QOL). Interventions to mitigate declines in function, ...
This paper investigates discriminating tongue features to distinguish between early stage BC patients and non-breast cancer individuals via non-invasive methods, expecting to detect BC in the early stage and give treatment in time to increase the recovery rate and lower relapse rate. Nine tongue feat...
Mortality from breast cancer (ICD10 C50): years of life lost (YLL) up to age 75, average annual YLL rate (per 10,000) and directly standardised average annual SYLL rate (per 10,000), 1999 and 2001 pooled Data covers strategic health authorities, former health authorities; primary care tr...
2A). Moreover, Trop2 can promote cell proliferation by regulating intramembrane proteolysis (RIP), especially in prostate cancer [15]. When Trop2 intracellular domain (ICD) and β-catenin co-localize in the nucleus after Trop2-ECD is shed, this leads to the upregulation of downstream cyclin ...
National study examining the treatment and outcome of patients diagnosed with breast cancer recurrence within the same breast/chest wall/nearby lymph glands,Leeds Teaching Hospitals NHS Trust,Observational,Not Applicable